As we only found one study that measured myostatin levels in four patients with infantile-onset SMA and long-term illness, we conducted an exploratory study considering the differences between cases and controls in serum myostatin and follistatin levels and their ratio, all as main outcomes, without statistical corrections for multiple comparisons. The gene discussed is MSTN; the disease is proximal spinal muscular atrophy.